Brogna, Carlo
Petrillo, Mauro
Cristoni, Simone
Querci, Maddalena
Piazza, Ornella
Van den Eede, Guy
2020-10-27
<p><strong>SUMMARY</strong></p>
<p>The frequent association between COVID-19 disease and different extrapulmonary clinical manifestations in symptomatic patients was reported recently.</p>
<p>The data reported here suggest an association between COVID-19 disease and the release in the body of (oligo-)peptides almost identical to toxic components of venoms from animals. The presence of these peptides opens new scenarios on the aetiology of the COVID-19 clinical symptoms observed up to now, including neurological manifestations.</p>
DECLARATION
The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication.
https://doi.org/10.5281/zenodo.4139341
oai:zenodo.org:4139341
eng
Zenodo
https://zenodo.org/communities/covid-19
https://doi.org/10.5281/zenodo.4139340
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
Covid-19
SARS-CoV-2
toxin-like peptides
Detection of toxin-like peptides in plasma and urine samples from COVID-19 patients
info:eu-repo/semantics/preprint